Hematologic parameters in pediatric uncomplicated Plasmodium falciparum malaria in sub-Saharan Africa

Piero Olliaro1, Abdoulaye Djimdé, Grant Dorsey

  • 1United Nations Children's Fund/United Nations Development Program/World Bank/World Health Organization Special Programme for Research and Training in Tropical Diseases, Geneva, Switzerland. olliarop@who.int

Insights

This study reveals that uncomplicated Plasmodium falciparum malaria in young African children causes modest hematologic changes, including decreased hemoglobin and platelets, and altered white blood cell counts. Neutropenia risk increased with follow-up time.

Area of Science:

  • Hematology
  • Infectious Diseases
  • Pediatrics

Background:

  • Hematologic alterations in Plasmodium falciparum malaria are not well-documented, especially in young African children.
  • Understanding these changes is crucial for managing malaria and its complications.

Purpose of the Study:

  • To investigate hematologic changes in young children with uncomplicated malaria.
  • To identify factors influencing these hematologic variations.

Main Methods:

  • Analysis of hematologic data from 3,044 children under five years old across seven randomized controlled trials.
  • Paired analysis comparing day 28 and baseline values in patients without treatment failure.
  • Multivariate random effects modeling to identify trends and explanatory variables.

Main Results:

  • A modest increase in leukocyte counts (5%) with a significant rise in neutrophils (43%) and a decrease in lymphocytes (-16%).
  • Significant decreases in hemoglobin (-13%) and platelets (-49%).
  • Increased risk of neutropenia with follow-up time, influenced by age, parasitemia, and treatment type.

Conclusions:

  • Plasmodium falciparum malaria induces distinct hematologic changes in young children.
  • Hematologic profiles evolve during follow-up, with neutropenia being a notable concern.
  • Artemisinin combination therapy may influence the risk of neutropenia.